CMA fines GlaxoSmithKline £38m for generics delay scam
12th Feb 2016 07:39
(ShareCast News) - The UK competition watchdog has fined GlaxoSmithKline for making illegal payments to rivals that delayed the launch of potentially cheaper generic medicine, potentially costing the NHS many millions. GSK has been fined £37.6m by the Competition and Markets Authority, with Merck fi
Read moreThursday broker round-up
11th Feb 2016 13:52
(ShareCast News) - ARM Holdings: JP Morgan reiterates neutral with a target of 950p, Exane BNP Paribas keeps at outperform, 1300p target, Deutsche Bank stays at hold, 1000p target, Goldman Sachs maintains buy with a target of 1400p, Citigroup keeps at neutral and Bryan, Garnier & Co reiterates buy.
Read moreFTSE 100 movers: StanChart leads market lower on Citi note
3rd Feb 2016 15:54
(ShareCast News) - The FTSE 100 was down again on Wednesday, dropping 78.22 points (1.32%) to 5,843.79 by mid-afternoon. Standard Chartered plunged after Citi lowered its target price on the shares of Asia-focused and commodity-exposed lender. The broker described the lender's valuation at 0.5 times
Read moreGlaxoSmithKline provides shot in the arm with final results
3rd Feb 2016 12:09
(ShareCast News) - GlaxoSmithKline posted full year results showing revenues increasing 6% and core earnings per share down 15%, slightly ahead of guidance, and reiterated its confidence that earnings growth would return in 2016 at double-digit levels. The pension fund favourite said it will pay an
Read moreWednesday preview: GSK reports fourth quarter earnings
2nd Feb 2016 12:44
(ShareCast News) - GlaxoSmithKline on Wednesday reports its fourth quarter earnings and a trading update on its 2015 full year results. UBS expects the pharmaceutical giant to report fourth quarter sales of £6.2m and core operating profit of £1.6bn. Core earnings per share (EPS) is forecast to co
Read moreGSK, AstraZeneca and J&J join forces with universities for tech transfer fund
25th Jan 2016 15:21
(ShareCast News) - AstraZeneca, GlaxoSmithKline and Johnson & Johnson and three leading UK universities are joining forces to try to significantly improve the speed that academic scientific research is translated into new medicines. The University of Cambridge, Imperial College London and University
Read moreSunday newspaper round-up: HMRC's new tax deals, Tesco's debt, Sainsbury's
24th Jan 2016 16:11
(ShareCast News) - In the wake of Google's £130m tax settlement with the UK taxman, other giant US corporations are close to shaking hands on their own deals. HM Revenue & Customs officials have confirmed to the Sunday Times that Amazon, Facebook, Microsoft and McDonald's are all close to agreements
Read moreStar fund manager Woodford calls for break-up of GlaxoSmithKline
8th Jan 2016 11:02
(ShareCast News) - Influential investor and founder of Woodford Investment Management Neil Woodford reckons GlaxoSmithKline should be split up. In an interview with the Radio 5 Live, Woodford said the FTSE 100 pharmaceuticals group needs radical restructuring and should be divided into separate comp
Read moreGlaxoSmithKline acquires HIV assets
18th Dec 2015 07:31
(ShareCast News) - GlaxoSmithKline's HIV business has reached a couple of deals with Bristol-Myers Squibb to acquire its late-stage HIV research and development assets as well as its portfolio of preclinical and discovery stage HIV research assets. Under the agreements, ViiV Healthcare will acquire
Read moreGlaxoSmithKline gets positive trial results for rheumatoid arthritis treatment
16th Dec 2015 14:10
(ShareCast News) - Pharmaceuticals giant GlaxoSmithKline announced positive top-line results from the phase III programme investigating sirukumab, which is used for the treatment of patients with moderately to severely active rheumatoid arthritis. Sirukumab, which is being developed as part of a col
Read moreBroker tips: IAG, BHP Billiton, AstraZeneca, GSK
2nd Dec 2015 13:11
(ShareCast News) - Clear skies lie ahead for the European Airlines sector going into the winter trading period, thanks to a favourable outlook for capacity growth and given the considerable fall in oil prices since August 2015, Nomura said. The global macroeconomic outlook, notably in the core UK an
Read moreAstraZeneca rallies on double upgrade from Morgan Stanley
2nd Dec 2015 10:00
(ShareCast News) - Pharmaceutical stocks got a boost on Wednesday as Morgan Stanley double upgraded AstraZeneca to 'overweight' from 'underweight' and said it was among its top picks. The bank, which lifted AZN's target price to 5,300p from 4,300p, said it has underperformed dramatically over the pa
Read moreGlaxoSmithKline's new severe asthma treatment gets FDA approval
5th Nov 2015 08:16
(ShareCast News) - GlaxoSmithKline's Nucala (mepolizumab) drug has received approval from the US Food and Drug Administration (FDA) for its Biologics License Application. The FTSE 100 pharmaceutical company revealed the news on Thursday. Nucala has been approved as an add-on maintenance treatment f
Read moreSunday newspaper round-up: Renminbi, GSK's pipeline, Brexit worry,
1st Nov 2015 16:08
(ShareCast News) - China's currency, the renminbi, could be promoted to the International Monetary Fund's list of global reserve currencies this week, sending an estimated $1trn (£650bn) of reserves flowing into the yuan. The momentous decision would give fresh impetus to Beijing's reform efforts, t
Read moreLondon close: Stocks rally ahead of Fed's interest rate decision
28th Oct 2015 16:14
(ShareCast News) - The London stock market closed higher on Wednesday before the Federal Reserve's decision on interest rates. The FTSE ended up 72.53 points to 6,437.80. The Fed releases its policy decision at 1800 GMT and is expected to keep rates at 0.25% amid low inflation and concerns about th
Read more